Want to join the conversation?
In March 2016, seven putative class action complaints have been filed in the US District Court for the Eastern District of Pennsylvania by indirect purchasers against $MYL, Mylan Pharmaceuticals & other pharma manufacturers alleging conspiracies to fix, raise, maintain & stabilize the prices of some product. $MYL intends to deny liability on this.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th